TCT-1 Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

Sorin J. Brener; Patrick W. Serruys; Martin B. Leon; Marie‐Claude Morice; David E. Kandzari; Roxana Mehran; A. Pieter Kappetein; Joseph F. Sabik; Yangbo Liu; Ovidiu Dressler; Ori Ben‐Yehuda; Gregg W. Stone

doi:10.1016/j.jacc.2018.08.1076

Related publications

Article2018

TCT-835 Validation of PARIS Risk Scores in Patients Treated With Everolimus-Eluting Stents for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

Sabato Sorrentino, Bimmer E. Claessen, Roxana Mehran, David E. Kandzari, Marie‐Claude Morice, Martin B. Leon, Bernard J. Gersh, Ori Ben‐Yehuda, Björn Redfors, Ovidiu Dressler, Stuart Pocock, A. Pieter Kappetein, Joseph F. Sabik, Patrick W. Serruys, Gregg W. Stone